Effects of telmisartan versus aliskiren on glucose and insulin metabolism and left ventricular mass in obese elderly patients with hypertension

Trial Profile

Effects of telmisartan versus aliskiren on glucose and insulin metabolism and left ventricular mass in obese elderly patients with hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2012

At a glance

  • Drugs Aliskiren (Primary) ; Telmisartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 May 2012 Results presented at the 27th Annual Scientific Meeting of the American Society of Hypertension.
    • 14 May 2012 New trial record
    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top